# Neurocrine Biosciences Presents New Tardive Dyskinesia Survey Results Showing Fewer Work and School Disruptions with INGREZZA® (valbenazine) Capsules

- Source: PR Newswire M&A
- Published: 2026-11-05T13:30:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-new-tardive-dyskinesia-survey-results-showing-fewer-work-and-school-disruptions-with-ingrezza-valbenazine-capsules-302930000.html
- Canonical: https://groundlevelnews.com/story/neurocrine-biosciences-presents-new-tardive-dyskinesia-survey-results--0f11a7/

Survey reveals work or school disruptions among adults with tardive dyskinesia declined from 57% before treatment to 21% after starting INGREZZA, with average missed days per month decreasing from 5.6 to 2.0 A separate post-hoc analysis of KINECT-PRO™ data showed patient-reported...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._